News
This approval offers a promising new targeted treatment for patients aged 12 and older with C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), ...
As the new chief strategy officer, Katy Sinnott will lead MSE Professional Services in long term strategic initiatives and ...
8d
Stockhead on MSNStudy backs Alterity’s innovative tool in diagnosing and monitoring MSA disease progression
Alterity Therapeutics has unveiled promising new research showing its novel brain imaging tool could play a key role in diagnosing and tracking Multiple System Atrophy (MSA), a rare and aggressive ...
Alterity’s cash position on 30 June 2025 was A$40.66M with operating cash outflows for the quarter of A$2.35M. In accordance with ASX Listing Rule 4.7C, payments of A$119k made to related parties and ...
4d
Stockhead on MSNAlterity reports positive results from open-label phase II trial of neurological disease drug
Alterity Therapeutics has reported positive topline results from its open-label phase II clinical trial of lead drug ATH434, ...
Data are Consistent with Phase 2 Double-Blind Trial and Support Advancement of ATH434 in MSA – MELBOURNE, Australia and SAN FRANCISCO, (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ...
The full publication can be accessed on Alterity’s website here.
Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and ...
Jack Rader, 6-4, 270-pound defensive lineman for the Bath Wildcats, picked up his fourth college offer last week from the ...
The top catchers from NCAA baseball and softball, along with the top catchers from select states in Reds Country, were ...
Mineros S.A. (TSX:MSA, MINEROS:CB) ("Mineros" or the "Company"), a leading gold producer in Latin America, announces that it ...
SuperSport anchor Julia Stuart shared breathtaking photos from her Monaco vacation with Maphuthi Hlako, leaving fans gushing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results